Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 5Terminated 4Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 4

Conditions

Neoplasms 474Carcinoma, Non-Small-Cell Lung 449Breast Neoplasms 331Neoplasm Metastasis 243Colorectal Neoplasms 214Melanoma 213Leukemia, Myeloid, Acute 191Multiple Myeloma 180Recurrence 169Ovarian Neoplasms 169Prostatic Neoplasms 163Lymphoma, Non-Hodgkin 149Lung Neoplasms 134Pancreatic Neoplasms 125Lymphoma 124Carcinoma, Renal Cell 112Leukemia, Lymphocytic, Chronic, B-Cell 111Squamous Cell Carcinoma of Head and Neck 110Stomach Neoplasms 92Carcinoma, Hepatocellular 89Lymphoma, Large B-Cell, Diffuse 88Leukemia 88Triple Negative Breast Neoplasms 86Lymphoma, Follicular 82Head and Neck Neoplasms 79Glioblastoma 75Myelodysplastic Syndromes 70Urinary Bladder Neoplasms 68Small Cell Lung Carcinoma 64Precursor Cell Lymphoblastic Leukemia-Lymphoma 55

Interventions

tusamitamab ravtansine 2pembrolizumab 1necitumumab 1Ramucirumab 1LY3023414 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Non-small Cell Lung Cancer Metastatic × Clear all
NCT04154956 2026-05-18

CARMEN-LC03

Sanofi

Phase 3 Terminated
389 enrolled 16 charts
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT04394624 2025-06-06

CARMEN-LC04

Sanofi

Phase 2 Terminated
31 enrolled 22 charts
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT02443337 2020-12-09

A Study of LY3023414 and Necitumumab in Squamous Lung Cancer

Eli Lilly and Company

Phase 2 Terminated
31 enrolled 14 charts
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT03477474 2019-10-10

GEODE

Guardant Health, Inc.

Terminated
311 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡